miRNAs involved in DNA damage response

No Pathway Network information available for miRNAs involved in DNA damage response

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with miRNAs involved in DNA damage response SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Leukemia, chronic lymphocyticEnrichmentATM, CCND1, TP534.87
2AdenocarcinomaEnrichmentATM, TP534.14
3Mantle cell lymphomaEnrichmentATM, CCND13.84
4Bladder cancerEnrichmentATM, CDKN1A, TP533.42
5Multiple endocrine neoplasia, type iEnrichmentCDKN1A, CDKN1B3.30
6B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)EnrichmentABL1, TP533.30
7Lip and oral cavity carcinomaEnrichmentABL1, TP532.81
8Myeloma, multipleEnrichmentATM, CCND1, TP532.58
9GliosarcomaEnrichmentATM, TP532.56
10Giant cell glioblastomaEnrichmentATM, TP532.51
11Microcephaly 12, primary, autosomal recessiveEnrichmentCDK62.31
12Bone marrow failure syndrome 5EnrichmentTP532.31
13Papilloma of choroid plexusEnrichmentTP532.31
14Basal cell carcinoma 7EnrichmentTP532.31
15Anaplastic thyroid carcinomaEnrichmentTP532.31
16Neuroendocrine tumorEnrichmentCDKN1B2.31
17Endometrial serous adenocarcinomaEnrichmentATM2.31
18Ductal carcinoma in situEnrichmentTP532.31
19Thyroid gland undifferentiated carcinomaEnrichmentTP532.31
20Small-cell carcinoma of the ovary of hypercalcemic typeEnrichmentTP532.31
21Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtypeEnrichmentTP532.31
22B-cell non-hodgkin lymphomaEnrichmentATM2.31
23Choroid plexus cancerEnrichmentTP532.31
24Pleomorphic xanthoastrocytomaEnrichmentTP532.31
25Precursor t-cell acute lymphoblastic leukemiaEnrichmentABL1, MYC2.25
26Pancreatic cancerEnrichmentATM, TP532.17
27Prostate cancerEnrichmentATM, TP532.05
28Colorectal cancerEnrichmentATM, CCND1, TP532.04
29Burkitt lymphomaEnrichmentMYC2.01
30Adrenocortical carcinoma, hereditaryEnrichmentTP532.01
31Cervical cancerEnrichmentTP532.01
32Histiocytoma, angiomatoid fibrousEnrichmentCREB12.01
33Lymphoma, hodgkin, classicEnrichmentTP532.01
34Multiple endocrine neoplasia, type ivEnrichmentCDKN1B2.01
35Congenital heart defects and skeletal malformations syndromeEnrichmentABL12.01
36Cardiac valvular dysplasia, x-linkedEnrichmentATM2.01
37Congenital fibrosarcomaEnrichmentTP532.01
38High grade gliomaEnrichmentATM2.01
39Li-fraumeni syndrome 1EnrichmentTP532.01
40SarcomaEnrichmentTP532.01
41Cervix carcinomaEnrichmentTP532.01
42Hodgkin's lymphomaEnrichmentTP532.01
43T-cell prolymphocytic leukemiaEnrichmentATM2.01
44Pleomorphic rhabdomyosarcomaEnrichmentTP532.01
45Ovarian cancerEnrichmentATM, CDKN1B, TP531.87
46Ataxia-telangiectasiaEnrichmentATM1.83
47Polycythemia veraEnrichmentATM1.83
48Osteogenic sarcomaEnrichmentTP531.83
49Nasopharyngeal carcinomaEnrichmentTP531.83
50Koolen-de vries syndromeEnrichmentATM1.83
51High-grade b-cell lymphoma double-hit/triple-hitEnrichmentMYC1.83
52Atypical teratoid rhabdoid tumorEnrichmentTP531.83
53Anaplastic astrocytomaEnrichmentTP531.83
54Squamous cell carcinomaEnrichmentTP531.83
55T-cell acute lymphoblastic leukemiaEnrichmentABL11.83
56Bone osteosarcomaEnrichmentTP531.83
57Melanoma of soft tissueEnrichmentCREB11.83
58Gastric cancerEnrichmentATM, TP531.72
59Small cell cancer of the lungEnrichmentTP531.71
60Thyroid cancer, nonmedullary, 1EnrichmentTP531.71
61Lung sarcomatoid carcinomaEnrichmentTP531.71
62Chronic myelogenous leukemia, bcr-abl1 positiveEnrichmentABL11.71
63Embryonal rhabdomyosarcomaEnrichmentTP531.71
64Primary hyperparathyroidismEnrichmentCDKN1B1.71
65Oculomotor apraxiaEnrichmentATM1.71
66Hereditary breast carcinomaEnrichmentATM, TP531.70
67Von hippel-lindau syndromeEnrichmentCCND11.61
68Rhabdomyosarcoma 2EnrichmentTP531.61
69LymphomaEnrichmentTP531.61
70GlioblastomaEnrichmentATM1.61
71Acute megakaryocytic leukemiaEnrichmentTP531.61
72Inherited cancer-predisposing syndromeEnrichmentATM, CDKN1B, TP531.56
73Li-fraumeni syndromeEnrichmentTP531.53
74Adrenocortical carcinomaEnrichmentTP531.53
75Clear cell renal cell carcinomaEnrichmentATM1.53
76Breast adenocarcinomaEnrichmentTP531.53
77Hereditary breast ovarian cancer syndromeEnrichmentATM, TP531.52
78Esophageal cancerEnrichmentTP531.47
79Squamous cell carcinoma, head and neckEnrichmentTP531.47
80Leukemia, chronic myeloidEnrichmentABL11.47
81Renal cell carcinoma, papillary, 1EnrichmentATM1.47
82Essential thrombocythemiaEnrichmentTP531.47
83Gallbladder cancerEnrichmentTP531.47
84Moyamoya angiopathyEnrichmentABL11.47
85Glioma susceptibility 1EnrichmentTP531.41
86Lymphoma, non-hodgkin, familialEnrichmentTP531.41
87Adult hepatocellular carcinomaEnrichmentTP531.36
88Primary hyperaldosteronismEnrichmentTP531.36
89Colonic benign neoplasmEnrichmentATM1.36
90Lynch syndrome 1EnrichmentATM1.32
91Familial colorectal cancerEnrichmentTP531.32
92Breast cancerEnrichmentATM, TP531.28
93Immune deficiency diseaseEnrichmentATM1.28
94Myelodysplastic syndromeEnrichmentTP531.28
95Uterine corpus cancerEnrichmentATM1.28
96Familial colorectal cancer type xEnrichmentATM1.28
97Breast-ovarian cancer, familial 1EnrichmentATM1.21
98Lung cancer susceptibility 3EnrichmentTP531.17
99Heart diseaseEnrichmentABL11.17
100Renal cell carcinoma, nonpapillaryEnrichmentATM1.14
101RhabdomyosarcomaEnrichmentTP531.12
102Polycystic liver diseaseEnrichmentCDC25A1.09
103Autosomal dominant polycystic liver diseaseEnrichmentCDC25A1.09
104Diffuse large b-cell lymphomaEnrichmentTP531.05
105Endometrial cancerEnrichmentATM1.01
106HepatoblastomaEnrichmentTP531.01
107Hepatocellular carcinomaEnrichmentTP530.99
108Diamond-blackfan anemia 1EnrichmentTP530.97
109Primary autosomal recessive microcephalyEnrichmentCDK60.83
110Diamond-blackfan anemiaEnrichmentTP530.79
111Leukemia, acute myeloidEnrichmentTP530.74
112MicrocephalyEnrichmentABL10.34

Loading...
Loading...
Loading...